NarratIR’s News & Insights brings together market commentary, perspective and analysis shaped by how capital markets actually function.
Our focus is on interpretation, not reaction - examining the forces influencing investor behaviour, disclosure expectations and market confidence across sectors and cycles.
This is where we share thinking developed through real engagement with listed companies, leadership teams and advisers - offering context when markets are volatile, clarity when narratives are tested, and perspective when judgement matters most.
Latest News & Insights
One of the Biggest Disconnects in ASX Biotech Isn’t Science - It’s Timing
Most ASX biotech timelines don’t fail - expectations do. Learn how timing, clinical uncertainty and communication shape investor trust through development cycles.
ASX Biotechs Do Not Move in Straight Lines
Biotech progress, capital, and investor attention rarely move in straight lines. Understanding this non linear reality is key to navigating ASX biotech market cycles.
When Biotech Goes Quiet, Credibility Speaks
Quiet periods are a structural feature of biotech markets. This article explores why credibility, not optimism, determines how ASX biotech companies perform when newsflow slows.
Where do investors really hear your story?
7 Aug: Where do investors really hear your story? (And are you even the one telling it?). In one of the largest ever investor sentiment survey's conducted in Australia, the primary sources influencing investment decisions in ASX-listed biotechs are….
Ready to regain control of your narrative?
Contact us for capital markets, investor relations and strategic communication support for ASX-listed companies and leadership teams navigating moments that matter.
NarratIR is located in Perth and Sydney, Australia with our team positioned Australia wide to service Australian and Asian capital market hours.
Get in touch, we’d love to talk…